Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-28

Clinical Trial Update: INVISION - An Observational Study to Explore Effectiveness, Tolerability and Safety of Paliperidone ER in Patients With Schizophrenia

View source ↗

Summary

An observational study evaluating the effectiveness, tolerability, and safety of paliperidone extended-release in adults with schizophrenia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Paliperidone ER (paliperidone)

Snippet

Sponsor: Janssen-Cilag B.V. | Conditions: Schizophrenia | Status: COMPLETED